AKRO icon

Akero Therapeutics

54 hedge funds and large institutions have $288M invested in Akero Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 17 closing their positions.

Holders
54
Holders Change
+6
Holders Change %
+12.5%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
13
Reduced
8
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AIP
51
Ameritas Investment Partners
Nebraska
$9K 400 +400 New
TAM
52
Tyers Asset Management
Texas
$8K 352
Citigroup
53
Citigroup
New York
$5K 211 +211 New
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$1K 44 +44 New
FCM
55
Farallon Capital Management
California
-150,000 Closed
MIM
56
Monashee Investment Management
Massachusetts
-110,000 Closed
Alyeska Investment Group
57
Alyeska Investment Group
Illinois
-64,688 Closed
MWNA
58
Marshall Wace North America
New York
-54,304 Closed
DIM
59
DC Investments Management
Virginia
-32,752 Closed
LCM
60
Landscape Capital Management
New Jersey
-25,352 Closed
ZP
61
Zimmer Partners
New York
-25,000 Closed
LCM
62
Laurion Capital Management
New York
-22,500 Closed
BCM
63
BlueCrest Capital Management
Jersey
-17,000 Closed
DKCM
64
Davidson Kempner Capital Management
New York
-15,000 Closed
Norges Bank
65
Norges Bank
Norway
-15,000 Closed
SG Americas Securities
66
SG Americas Securities
New York
-10,000 Closed
MCM
67
Moore Capital Management
New York
-10,000 Closed
PHK
68
Point72 Hong Kong
Hong Kong
-4,008 Closed
TRCT
69
Tower Research Capital (TRC)
New York
-1,381 Closed
GAM
70
Griffin Asset Management
New York
-1,300 Closed
CCA
71
Catalyst Capital Advisors
New York
-416 Closed
CFGS
72
Concourse Financial Group Securities
Alabama